AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | A210651 | RHODES PHARMACEUTICALS LP
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Shire Development LLC et al v. Rhodes Pharmaceuticals L.P. 2 patentsANDA 210651dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate | D. Del. | 2017-12-21 | Terminated 2018-04-26 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.6118
per ea
Lowest NADAC/Unit
$0.4661
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 42858072001DEXTROAMP-AMPHET ER 20 MG CAP | $0.6118 | EA | Generic | — | 2026-06-17 |
| 42858021501DEXTROAMP-AMPHET ER 15 MG CAP | $0.5546 | EA | Generic | — | 2026-06-17 |
| 42858032501DEXTROAMP-AMPHET ER 25 MG CAP | $0.5470 | EA | Generic | — | 2026-06-17 |
| 42858061001DEXTROAMP-AMPHET ER 10 MG CAP | $0.5315 | EA | Generic | — | 2026-06-17 |
| 42858093001DEXTROAMP-AMPHET ER 30 MG CAP | $0.5227 | EA | Generic | — | 2026-06-17 |
| 42858005501DEXTROAMP-AMPHET ER 5 MG CAP | $0.4661 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.